Treatment Itinerary and Health System Delay Among Patients With Pulmonary Tuberculosis in Ile-ife, South-western Nigeria

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background Timely diagnosis and initiation of appropriate treatment are still being impeded by health system delays (HSD) between the first formal health-seeking and initiation of tuberculosis treatment. This study aimed to investigate the treatment itinerary and determinants of HSD among patients with pulmonary tuberculosis in Ile-Ife, Southwestern Nigeria. Methods This descriptive cross-sectional study involved patients with pulmonary tuberculosis in the Directly Observed Treatment Short Course (DOTS) centres in Ile-Ife. A multistage sampling technique was used to recruit 320 patients, and an interviewer-administered questionnaire was used to obtain data. Descriptive and inferential analyses were done, and a p-value ˂ 0.05 was considered statistically significant Results Only 10.3% of patients sought formal healthcare as their initial action, with 75.6% of them waiting 21 days or more from the onset of symptoms before their first formal health-seeking. The majority of patients (83.1%) visited one or two formal health-care providers for the diagnosis. The median HSD was 13.5 days (Range 0–105). The factors that were independently related to prolonged HSD were monthly family income (Odds Ratio [OR] 1.73; 95% Confidence Interval [CI] 1.02–2.94; p = 0.04), number of health-seeking encounters before TB diagnosis (OR, 0.23; 95% CI, 0.08–0.68; p < 0.01), and the first health facility visited (OR, 0.25; 95% CI, 0.14–0.44; p < 0.01). Conclusion A Significant HSD existed among patients with tuberculosis. These findings emphasise the necessity of increasing diagnostic capacity, decentralising services, and training frontline providers, while enhancing financial protection. Clinical trial number: not applicable

Article activity feed